RavenQuest BioMed’s Four Pillar Approach to the Cannabis Industry
January 4th, 2018
Exclusive, News, Top News
Canada’s cannabis industry is projected to reach C$22.6 billion in size over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. Investors have many different options for capitalizing on this growing market, but the increasingly crowded market could see more competition over the coming years. The best opportunities are companies that have cultivated a durable competitive advantage.
RavenQuest BioMed Inc.’s (CSE: RQB) competitive advantages are focused on partnerships with indigenous populations and solid fiscal management. By working with indigenous populations, the company hopes to develop a diverse range of profitable partnerships while building out its own production later this year. Management aims to accomplish these goals by taking a four pillar approach to the market.
#1: Partnerships with Indigenous Peoples
RavenQuest BioMed provides indigenous populations with a turnkey solution for the production and sale of cannabis on their sovereign land. Under the guidance of Bill Robinson, the company has already identified and engaged with an impressive list of prospective Indigenous Peoples partners. These partnerships could lead to a steady stream of positive announcements of new production licenses and capacity expansion over the coming year.
Bill Robinson serves as the head of Government/Indigenous Relations and Strategic Partnerships for the company. Over his 34-year career with the Royal Canadian Mounted Police (RCMP), Mr. Robinson served in communities across Canada, including 18 years in Alberta. He worked closely with many organizations and developed close and trusted relationships with Indigenous communities, providing valuable connections for his current role.
#2: Near-term Production by Mid-2018
RavenQuest BioMed recently acquired a 100% interest in the Alberta-based Green Biotech, which expects to complete construction on a 35,500 sq. ft. facility by mid-2018. At capacity, the facility is expected to produce 7,000 kilograms of dried cannabis each year after spending approximately $14 million to $16 million to complete the facility. The facility is expected to have one of the highest yields per square foot and lowest costs in the industry.
While the facility must still be approved by Health Canada, the application and facility design was completed by the Services Group, which has a 100% success rate in moving applicants from pre-license inspection to approval. The company’s investment and acquisitions division will also continue to focus on making equity investments in select licensed producers under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
#3: Immediate Revenue from Management Services
RavenQuest BioMed has already provided consulting services to 10 licensed producers and helped them navigate the complex licensing process prior to going public. With a steady pipeline of management services contracts, the company anticipates generating near-term revenue while it builds new partnerships and production licenses over the coming year. These revenue could help reduce the need to raise capital and preserve shareholder value.
#4: Research & Development
RavenQuest BioMed continues to identify and develop research partnerships designed to maximize flower production and provide cultivar recognition and stabilization of the cannabis plant. By focusing on stabilizing the expression of each crop and improving yield per square foot, the company expects to increase the profitability and scale of its operations and its partnerships’ operations over time. The result is greater revenue and profitability for investors through a focus on cost-effective cultivation.
RavenQuest BioMed Inc.’s (CSE: RQB) four pillar approach to the cannabis industry sets it apart from many other companies in the space. With near-term management services revenue and production on the horizon, the company is well positioned to generate both short- and long-term value for shareholders. Its focus on indigenous populations also provides it with a unique advantage when it comes to cultivating mutually-beneficial partnerships.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.